Publications

Latest publication 06/29/2022

Development of a traditional Chinese medicine-based agent for the treatment of c

We developed an integrated, multi-tiered strategy involving both in vitro and in vivo muscle atrophy platforms to identify traditional Chinese...

Array
(
    [id_prestablog_news] => 1548
    [id_shop] => 1
    [date] => 2022-06-29 00:00:00
    [date_modification] => 2024-02-09 14:15:13
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 3288
    [id_lang] => 1
    [title] => Development of a traditional Chinese medicine-based agent for the treatment of c
    [paragraph] => Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia
    [content] => 

Authors
KC Wu, PC Chu, YJ Cheng et al


Lab
School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan

Journal
Journal of Cachexia, Sarcopenia and Muscle

Abstract
We developed an integrated, multi-tiered strategy involving both in vitro and in vivo muscle atrophy platforms to identify traditional Chinese medicine (TCM)-based anti-cachectic agents. In the initial screening, we used inflammatory cytokine-induced atrophy of C2C12 myotubes as a phenotypic screening platform to assess the protective effects of TCMs. The selected TCMs were then evaluated for their abilities to protect Caenorhabditis elegans from age-related reduction of mobility and contractility, followed by the C-26 colon adenocarcinoma mouse model of cachexia to confirm the anti-muscle atrophy effects (body/skeletal muscle weights, fibre size distribution, grip strengths, and serum IL-6). Transcriptome analysis, quantitative real-time polymerase chain reaction, and immunoblot ting were performed to gain understanding of the potential mechanism(s) by which effective TCM protected against C26 tumour-induced muscle atrophy

BIOSEB Instruments Used
Grip strength test (BIO-GS3)

[meta_description] => [meta_keywords] => https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcsm.13028 [meta_title] => [link_rewrite] => development-of-a-traditional-chinese-medicine-based-agent-for-the-treatment-of-cancer-cachexia [actif_langue] => 1 [read] => 902 [count_comments] => 0 [id] => 1548 [categories] => Array ( [90] => Array ( [id_prestablog_categorie] => 90 [title] => Cancer [link_rewrite] => Cancer ) [65] => Array ( [id_prestablog_categorie] => 65 [title] => Muscular atrophy [link_rewrite] => atrophie ) [2] => Array ( [id_prestablog_categorie] => 2 [title] => Publications [link_rewrite] => publications ) ) [authors] => [paragraph_crop] => Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia [link_for_unique] => 1 [products_liaison] => Array ( [48] => Array ( [name] => Grip strength test [description_short] =>

An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.

New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

forrats.pngformice.png

[thumb] => [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg [image_presente] => 1 [link] => https://preprod.bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html ) ) ) 1
Read more

Filters

Applications

Dates